Animal Model Market Size to Attain USD 5.72 Billion by 2033

According to a recent research report titled “Animal Model Market (By Application: Cancer, Immunological Disease, Infectious Disease, Others; By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Others; By End-use: Pharmaceutical & Biotechnology Companies, Academic Research Institute, Contract Research Organization) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033″ published by Precedence Research, the global animal model market size is projected to touch around USD 5.72 billion by 2033 and growing at a CAGR of 8.71% over the forecast period 2024 to 2033. This comprehensive study examines various factors and their impact on the growth of the animal model market.

Key Points

• North America led the market with the largest market share of 50% in 2023.
• By application type, the cancer segment has held the largest market share of 44% in 2023.
• By animal type, the mice & rat segment held the largest share of 53% in 2023.
• By end use, in 2023, the pharmaceutical & biotechnology companies segment has captured more than 40% of market share in 2023.

The report primarily focuses on the volume and value of the animal model market at the global, regional, and company levels. At the global level, the report analyzes historical data and future prospects to present an overview of the overall market size. Regionally, the study emphasizes key regions such as North America, Europe, the Middle East & Africa, Latin America, and others.

Furthermore, the research report provides specific segmentations based on regions (countries), companies, and all market segments. This analysis offers insights into the growth and revenue trends during the historical period of 2021 to 2033, as well as the projected period. By understanding these segments, it becomes possible to identify the significance of different factors that contribute to market growth.

Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3890

The research also highlights significant progressions in both organic and inorganic growth strategies within the global animal model market. Numerous companies are placing emphasis on new product launches, gaining product approvals, and implementing various business expansion tactics. Moreover, the report presents detailed profiles of firms operating in the animal model market, along with their respective market strategies. Additionally, the study concentrates on prominent industry participants, furnishing details such as company profiles, product offerings, financial updates, and noteworthy advancements.

Animal Model Market Scope

Also read: Recombinant Antibodies Market Size to Attain USD 23.34 Bn by 2033

Major Key Points Covered in the Report:

Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides an analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.

Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.

Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.

Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.

Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.

Market Key Players

The report incorporates company profiles of key players in the market. These profiles encompass vital information such as product portfolio, key strategies, and a comprehensive SWOT analysis for each player. Additionally, the report presents a matrix illustrating the presence of each prominent player, enabling readers to gain actionable insights. This facilitates a thoughtful assessment of the market status and aids in predicting the level of competition in the animal model market.

Animal Model Market Companies

• Charles River Laboratories
• The Jackson Laboratory
• genOway
• Taconic Biosciences, Inc.
• Janvier Labs
• Harbour BioMed
• Crown Bioscience
• Inotiv
• BIOCYTOGEN
• BioSpherix, Ltd.

Segments Covered in the Report

By Application

• Cancer
• Immunological Disease
• Infectious Disease
• Others

By Animal Type

• Mice
• Rat
• Guinea Pigs
• Rabbits
• Hamsters
• Others

By End-use

• Pharmaceutical & Biotechnology Companies
• Academic Research Institute
• Contract Research Organization

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Animal Model Market 

5.1. COVID-19 Landscape: Animal Model Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Animal Model Market, By Application

8.1. Animal Model Market, by Application, 2024-2033

8.1.1 Cancer

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Immunological Disease

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Infectious Disease

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Animal Model Market, By Animal Type

9.1. Animal Model Market, by Animal Type, 2024-2033

9.1.1. Mice

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Rat

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Guinea Pigs

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Rabbits

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Hamsters

9.1.5.1. Market Revenue and Forecast (2021-2033)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Animal Model Market, By End-use 

10.1. Animal Model Market, by End-use, 2024-2033

10.1.1. Pharmaceutical & Biotechnology Companies

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Academic Research Institute

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Contract Research Organization

10.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Animal Model Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Application (2021-2033)

11.1.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.1.3. Market Revenue and Forecast, by End-use (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.1.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.1.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.1.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.1.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.6.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.7.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.6.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.7.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.6.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.7.3. Market Revenue and Forecast, by End-use (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.5.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.5.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.5.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.5.5.3. Market Revenue and Forecast, by End-use (2021-2033)

Chapter 12. Company Profiles

12.1. Charles River Laboratories

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. The Jackson Laboratory

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. genOway

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Taconic Biosciences, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Janvier Labs

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Harbour BioMed

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Crown Bioscience

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Inotiv

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. BIOCYTOGEN

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. BioSpherix, Ltd.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Why should you invest in this report?

This report presents a compelling investment opportunity for those interested in the global animal model market. It serves as an extensive and informative guide, offering clear insights into this niche market. By delving into the report, you will gain a comprehensive understanding of the various major application areas for animal model. Furthermore, it provides crucial information about the key regions worldwide that are expected to experience substantial growth within the forecast period of 2024-2033. Armed with this knowledge, you can strategically plan your market entry approaches.

Moreover, this report offers a deep analysis of the competitive landscape, equipping you with valuable insights into the level of competition prevalent in this highly competitive market. If you are already an established player, it will enable you to assess the strategies employed by your competitors, allowing you to stay ahead as market leaders. For newcomers entering this market, the extensive data provided in this report is invaluable, providing a solid foundation for informed decision-making.

Some of the key questions answered in this report:       

• What is the size of the overall Animal model market and its segments?
• What are the key segments and sub-segments in the market?
• What are the key drivers, restraints, opportunities and challenges of the Animal model market and how they are expected to impact the market?
• What are the attractive investment opportunities within the Animal model market?
• What is the Animal model market size at the regional and country-level?
• Who are the key market players and their key competitors?
• What are the strategies for growth adopted by the key players in Animal model market?
• What are the recent trends in Animal model market? (M&A, partnerships, new product developments, expansions)?
• What are the challenges to the Animal model market growth?
• What are the key market trends impacting the growth of Animal model market?

 

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

---